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Özet: Obstrüktif uyku apnesinde oksijen satürasyonunun
%90-95 alt›nda kald›¤› durumlarda uyku süresi ile klinik
ve laboratuvar bulgular› aras›ndaki iliflki 
Amaç: Bu çal›flman›n amac› obstrüktif uyku apnesinde (OUA); CT90 ve
CT95 de¤erleri ile fizik muayene parametreleri, kronik metabolik hasta-
l›klar, sigara içimi, ortalama trombosit hacmi, beyin manyetik rezonans
görüntülemesinde (MRG) hiperintens odak varl›¤› ve say›s› aras›ndaki
iliflkileri saptamakt›.  
Yöntem: Hastanemiz uyku laboratuvar›nda 2011–2014 tarihleri ara-
s›nda polisomnografi uygulanan 1154 olgu retrospektif olarak taran-
d›. Bu hastalardan kulak burun bo¤az muayenesi yap›lm›fl, beyin
MRG, CBC ve biyokimya tetkikleri bulunan 72 olgu çal›flmaya dahil
edildi. Tüm hastalarda ayr›nt›l› anamnez ile birlikte (1) Vücut kitle in-
deksi (VK‹), (2) boyun ve kar›n çevresi ölçümü, (3) orofarenks muaye-
nesi, (4) fiberoptik endoskop ile Müller manevras› uygulamas›, (5) Ep-
worth uyku skalas› ve (6) polisomnografi (PSG) tetkikleri yap›ld›. 
Bulgular: Olgular›n OUA fliddetine göre da¤›l›m›: %22.2 basit horlama,
%19.4 hafif, %19.4 orta ve %38.9 a¤›r OUA idi. Çoklu do¤rusal regresyon
analizi yap›ld›¤›nda apne-hipopne indeksi (AH‹) (p=0.026) ve vücut kitle
indeksinin (VK‹) (p=0.013) CT90’› etkileyen ba¤›ms›z de¤iflkenler oldu¤u
(R2=%49) görüldü. Çoklu do¤rusal regresyon analizi yap›ld›¤›nda sigara
içimi (p=0.001), AH‹ (p=0.003) ve hiperintens odak say›s›n›n (p=0.013)
CT95’i etkileyen ba¤›ms›z de¤iflkenler oldu¤u (R2=%47.9), diyabet ve VK‹
ile CT95 iliflkisinin istatistiksel olarak anlaml› olmad›¤› görüldü. 
Sonuç: CT95 de¤erinin sigara içiminden etkileniyor olmas›, ancak retro-
palatal ve retroglossal Müller evreleri ile istatistiksel anlaml› iliflkisi bu-
lunmamas› nedeniyle, obstrüktif uyku apnelilerde kronik entermitan hi-
poksi fliddetinin de¤erlendirilmesinde CT90 de¤erinin dikkate al›nmas›-
n›n daha uygun oldu¤u düflünülmüfltür. Bununla birlikte CT90 de¤erinin
AH‹ ile korelasyonu ST90 için literatürde belirtilen de¤ere yak›n, ancak
daha güçlü de¤ildir.   
Anahtar sözcükler: Obstrüktif uyku apnesi, uyku süresi, klinik, labora-
tuvar.
Abstract
Objective: The aim of the present study was to determine correlations
between CT90 and CT95 values and physical examination parameters,
chronic metabolic diseases, smoking, mean platelet volume, cerebral
magnetic resonance imaging (MRI), presence and number of hyperin-
tense foci in obstructive sleep apnea (OSA).   
Methods: A total of 1154 patients who underwent polysomnography in
our sleep laboratory between 2011 and 2014 were screened retrospec-
tively. Among them, 72 cases who underwent ear, nose and throat exam-
inations, cerebral MR, CBC and biochemical tests were included in the
study. All patients underwent a detailed anamnesis together with (1)
measurements of BMI (body mass index) (2) circumferences of neck and
abdomen, (3) examination of oropharynx, (4) Müller maneuver with the
aid of fiberoptic endoscope, (5) estimation of Epworth sleep scale scores,
(6) and polysomnographic (PSG) tests. 
Results: According to the severity of OSA, the patients had simple snor-
ing (22.2%), mild (19.4%) and severe OSA (38.9%). In multivariate
regression analysis, body mass index (BMI) (p=0.026) and apnea/hypop-
nea index (AHI) (p=0.013) were seen as independent variables affecting
CT90 (R2=49%). Multivariate linear regression analysis demonstrated that
independent variables of smoking (p=0.001), AHI (p= 0.003) and number
of hyperintense foci (p=0.013) affected CT95 (R2=%47.9), while relation-
ships between diabetes, BMI and CT95 were not statistically significant. 
Conclusion: Since CT95 values are affected by smoking without any statis-
tically significant correlation with retropalatal and retroglossal Müller
stages, we think that consideration of CT90 value will be more appropriate
in the evaluation of the severity of chronic intermittent hypoxia in patients
with obstructive sleep apnea. However, the correlation between CT90 value
and AHI is closer to the value indicated in the literature, but not stronger. 
Keywords: Obstructive sleep apnea, duration of sleep, clinical, labo-
ratory. 
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Obstructive sleep apnea (OSA) is a prevalently seen syn-
drome characterized by recurrent collapses and intermittent
hypoxia of upper respiratory tract. Impairment of gas
exchange leads to oxygen desaturation, hypercapnia and
fragmentation of sleep with resultant metabolic, neurocog-
nitive and cardiovascular disorders.[1] Apnea/hypopnea index
(AHI) is used in the determination of the severity of OSA;
however, AHI does not provide information about the dura-
tion of apnea and its morphology.[2] Whereas, the longer the
apneic episodes persist, the deeper is the hypoxia.
Therefore, AHI does not fully reflect pathophysiologic
characteristics of hypoxia.[3] Cases with similar AHI values
may have different clinical symptoms and sign.[4,5] Chronic
intermittent type is generally described as recurrent hypox-
emic attacks followed by periodic reoxygenation.[6]
Nowadays, a globally accepted quantitative clinical test
which can be used in the measurement of the severity of
hypoxia does not exist.[1]
In recent years, due to a direct correlation between ST90
value, severity and duration of hypoxia, OSA has attracted
gradually increasing attention in investigations performed
on OSA.[7–9] Bostanci et al. investigated the relationship
between various polysomnographic parameters and ST90
and reported age, body mass index (BMI), male gender,
AHI, mean oxygen saturation as independent variables
affecting ST90.[1] They indicated that AHI and ST90 values
should be evaluated in combination as an appropriate
approach to the determination of prognosis of the disease
and selection of suitable treatment modality for the patient.
1 In this study, the ratio between total of sleep durations
where oxygen saturations stayed below 90, and 95% and
total duration of sleep was determined as CT90 and CT95 val-
ues, respectively. Since these values represent the ratio
between the time passed at the hypoxic state and total dura-
tion of sleep, they are considered to be a better indicator
than ST90 values. 
The aim of the present study was to determine correla-
tions between physical examination parameters, chronic
metabolic diseases, smoking, mean platelet volume, cerebral
magnetic resonance imaging (MRI), presence and number
of hyperintense foci.  
Materials and Methods
A total of 1154 patients who underwent polysomnography
in our sleep laboratory between 2011 and 2014 were
screened retrospectively. Among them, those who under-
went ear, nose and throat examinations, cerebral MR, CBC
and biochemical tests were included in the study.
All patients underwent a detailed anamnesis together
with (1) measurements of BMI, (2) circumferences of neck
and abdomen, (3) examination of oropharynx, (4) Müller
maneuver with the aid of fiberoptic endoscope, (5) estima-
tion of Epworth sleep scale scores, (6) and polysomnograph-
ic (PSG) tests. Hypertension, other cardiovascular diseases,
diabetes, and smoking habits were questioned. Tonsil size
was graded. The patients were requested to open their
mouths with their tongues remaining in their mouths. Oral
cavity was inspected, and the position of the palate and root
of the tongue was evaluated and modified Malampati score
was determined. All patients were subjected to Müller
maneuvers while seated and degree of obstruction at the
level of the soft palate and tongue root was assessed. For the
assessment of an upper respiratory tract of a patient seated
erect, a fiberoptic endoscope was inserted through nasal
route complying with the Frankfurt line parallel to the
ground. Fibroscope was advanced till epiglottis was visible.
During Müller maneuver (forced inspiration with the closed
mouth and nose) retropalatal and retroglossal regions were
observed. Müller maneuvers were repeated three or more
times in case of need till we were certain that the patient
made a forceful inspiration. The degree of retropalatal and
retroglossal collapse was staged (Table 1). 
Patients with chronic renal, heart or liver failure, abnor-
mal pulmonary functions or sleep disorders other than OSA
and patients who experienced previously any surgical inter-
vention or those using any respiratory device for their treat-
ment were not included in the study. 
All patients underwent all-night polysomnographic
examination in the Sleep Laboratory of Chest Diseases,
Alanya Hospital of Baflkent University using 44-channel
Compumedics brand E series (Abbotsford, Australia) com-
puterized system under the surveillance of an experienced
technician. Polysomnographic examinations included
(EEG), 2-channel electro-oculography (EOG), single-chan-
nel submental muscle electromyography (EMG), 2-channel
EMG whose electrodes were placed on both anterior tibial
muscles, 1-channel nasal cannula for the measurement of
oronasal airflow, 1-channel oronasal thermal sensor, 2-
channel inductive plethysmography to display respiratory
efforts of thorax, and abdomen, “body position” sensor to
determine position of the body, pulse oximetry device with
a single-channel finger probe to measure arterial oxyhemo-
globin (SpO2) concentration and simultaneous video
recordings. Apnea was defined as cessation of respiration for
≥10 seconds. At least 50% drop in respiratory effort togeth-
er with 4% drop in SaO2 was considered as hypopnea. AHI
is the number of apneas and hypopneas per hour (Table 1).
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Statistical analysis
Data were analyzed using the IBM Statistical Package for
Social Sciences v21 (SPSS Inc., Chicago, IL, USA). A nor-
mal distribution of the quantitative data was checked using
Shapiro-Wilk test. Parametric tests (independent-samples
t-test and posthoc Tukey test) were applied to data of nor-
mal distribution and non-parametric tests (Mann-Whiney
U test and Kruskal-Wallis test) were applied to data of
questionably normal distribution. To calculate correlation
coefficients, Spearman correlation was used. Data are
expressed as mean±SD or median (interquartile range), as
appropriate. Statistical significance was considered as
p<0.05.  
Results
General characteristics of the patients are seen in Table 2.
The mean age of the patients was 47.6±12.2 (range: 23 to
75) years. The study population consisted of 64 (88.9%)
male and 8 (11.1%) female patients. According to severity
of OSA, the patients had simple snoring (22.2%), mild
(19.4%) and severe OSA (38.9%). 
Based on Spearman correlation analysis CT90 was corre-
lated with Epworth sleep score (r=0.29, p=0.013), AHI
(r=0.713, p<0.001) and BMI (r=0.549, p<0.001). However,
variables of diabetes mellitus (p=0.040), retropalatal Müller
stage (p=0.018) and retroglossal Müller stage (p=0.034)
affected CT90 (Table 3). However, in multivariate regres-
sion analysis only BMI (p=0.026) and AHI (p=0.013) were
Parameter Stage Description
Apnea hipopnea 1 (primary snoring) AHI ≤ 5
index (AHI) 2 (mild) 5 < AHI ≤ 15
3 (moderate) 15 < AHI ≤ 30
4 (severe) >30
Body mass index 1 <25
(BMI) (kg/m2) 2 25 ≤ BMI ≤ 30
3 30 < BMI ≤ 40
4 >40
Size of the tonsils 0 Tonsillectomized
1 Tonsils are in the tonsillar 
fossa, lateral to the plicas
2 Occupies 25–50% of 
oropharynx
3 Occupies 50–75% of 
oropharynx 
4 Occupies >75% of 
oropharynx; it nearly 
joins at midline
Modified Malampati 1 Soft palate, plicas and 
tonsils can be seen
2 Uvula, plicas and upper 
poles of tonsils can be seen
3 Soft palate can be partially 
seen
4 Only hard palate is visible
Retropalatal Müller 1 Less than 25 collapse of 
stage pharyngeal walls during 
Müller maneuver 
2 25–50%
3 50–75%
4 >75%
Retroglossal Müller 1 Vallecula and vocal cords 
stage are completely visible
2 Vallecula and vocal cords 
are partially visible
3 Root of the tongue touches 
epiglottis, amd arythenoids 
are visible
4 Root of the tongue pushes 
epiglottis and arythenoids 
cannot be seen.
Table 1. Staging system of polysomnographic and physical examination
findings used in patients evaluated for OSA.
mean±SD min–max
CT90, % 7.16±14.68 0–75.6
CT95, % 44.6±31.57 0–100
Epworth sleep score 9.13±5.18 0–24
Hemoglobin (g/dL) 14.43±1.29 10.2–17.1
Mean platelet volume (fl) 7.86±1.51 5–15.3
Apnea hypopnea index 28.15±24.84 0–93
Body mass index (kg/m2) 31.12±5.33 21.9–48
Table 2. General characteristics of the patients (n=72).
n %
Hyperintense foci Absent 38 52.8
Present 34 47.2
Number of hyperintense Absent 34 47.2
foci 1–4 16 22.2
≥5 22 30.6
Hypertension Absent 40 55.6
Present 32 44.4
Diabetes Absent 58 80.6
Present 14 19.4
Cardiovascular disease Absent 59 81.9
Present 13 18.1
Hyperlipidemia Absent 54 75.0
Present 18 25.0
Smoking Absent 46 63.9
Present 26 36.1
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seen as independent variables affecting CT90 (R2=49%)
(Table 4). Spearman correlation analysis revealed correla-
tion between CT95 and AHI (r=0.604, p<0.001) and BMI
(r=0.473, p<0.001). However, variables of diabetes
(p=0.005), smoking (p=0.017) and number of hyperintense
foci (p=0.011) affected CT95 (Table 3). Multivariate linear
regression analysis demonstrated that independent variables
of only smoking (p=0.001), AHI (p=0.003) and number of
hyperintense foci (p=0.013) affected CT95 (R2=47.9%),
while relationships between diabetes, BMI and CT95 were
not statistically significant (Table 4). 
Discussion
The total duration of sleep where oxygen saturation
remains below 90% and 95%, is an easily measurable
objective parameter. In this study a statistically significant
correlation was not detected between retropalatal Müller
stage, retroglossal Müller stage and CT95 values, However,
correlations between retropalatal Müller stage and ret-
roglossal Müller stage CT90 values were seen (p=0.018 and
p=0.034, respectively). 
Li and Jin reported a strong correlation between AHI
and total duration of apnea (r=0.770 and 0.776, respective-
ly).[7] In our study, a strong correlation was found between
CT90 value and AHI; however, it was not so strong as ST90
value indicated in the study by Li and Jin. (r=0.0713). A
moderate degree of correlation was found between CT95
and AHI (r=0.604). Besides, a correlation between
Epworth sleep score and CT90 (r=0.290) was found,
whereas, a statistically significant correlation was not
detected between CT95 and EUS. 
Table 3. Factors affecting CT90 and CT95.
CT90 CT95
Median [min–max] p value Median [min–max] p value
Hyperintense foci Absent 0.40 [0–75.63] 0.364 31.7 [0.04–100] 0.146
Present 1.11 [0–41.02] 48.6 [2.86–92.21]
Hypertension Absent 0.61 [0–48.66] 0.692 36.4 [0.04–96.61] 0.362
Present 0.78 [0–75.63] 44.1 [1.63–100]
Diabetes Absent 0.40 [0–48.66] 0.040 30.0 [0.04–100] 0.005
Present 4.46 [0–75.63] 74.3 [12.3–92.6]
Cardiovascular Absent 0.64 [0–75.63] 0.482 42.3 [0.04–100] 0.703
Present 0.32 [0–41.02] 43.4 [1.63–86.3]
Hyperlipidemia Absent 0.61 [0–75.63] 0.696 41.4 [0.04–96.61] 0.830
Present 1.04 [0–60.58] 51.5 [1.63–100]
Smoking Absent 0.31 [0–60.58] 0.088 28.0 [0.04–89.2] 0.017
Present 2.21 [0.01–75.63] 63.9 [1.12–100]
Gender Male 0.71 [0–75.63] 0.405 44.9 [0.04–100] 0.333
Female 0.27 [0–33.16] 22.2 [0.05–92.12]
Number of hyperintense foci WML absent 0.40 [0–75.63] 0.319 31.7 [0.04–100] 0.011
WML 1–4 0.42 [0–33.16] 24.3 [0.13–91.85]
WML >5 1.72 [0.05–41.02] 62.4 [12.91–92.21]
Mallampati stage 1 0.25 [0.01–33.16] 0.276 43.4 [0.05–92.12] 0.169
2 0.46 [0–41.02] 29.5 [0.13–100]
3-4 0.85 [0–75.63] 65.0 [0.04–92.63]
Tonsillar stage 1-2 0.30 [0–60.58] 0.128 30.9 [0.04–92.21] 0.213
3 0.91 [0–75.63] 46.4 [1.63–100]
4 7.34 [0.09–19.14] 53.6 [26.9–86.3]
Retropalatal Müller stage 1 0.17 [0–6.51] 0.018 20.3 [0.05–91.85] 0.063
2 0.27 [0–33.16] 26.1 [0.13–96.61]
3 1.80 [0.04–60.58] 54.8 [6.93–92.21]
4 6.11 [0–75.63] 60.2 [0.04–100]
Retroglossal Müller stage 1 0.62 [0–41.02] 0.034 35.6 [1.63–100] 0.072
2 0.32 [0–36.29] 32.8 [0.04–96.61]
3-4 17.1 [0.05–75.63] 79.5 [9.96–92.63]
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Recent studies have demonstrated the close relation-
ship between obesity and OSA, insulin resistance and
metabolic syndrome.[10,11] The studies performed more
recently have detected that metabolic dysfunction devel-
oped in OSA which is not only correlated with obesity but
also related closely to the severity of OSA irrespective of
the presence of obesity.[12,13] Punjabi et al. demonstrated
that the insulin resistance developed in patients with OSA
increases in parallel with the increase in the severity of the
disease and pointed out to the severity of oxygen desatura-
tion as one of the important factors which increase the
insulin resistance.[14,15] In our study, CT90 and CT95 values
were found to be correlated with the presence of diabetes
(p=0.040 and p=0.005, respectively). 
In obstructive sleep apnea, hyperintense foci (= alter-
ations in white matter) on cerebral periventricular and
subcortical areas at T2-weighted and FLAIR (fluid atten-
uated inversion recovery) sequences of magnetic reso-
nance imaging in obstructive sleep apnea were found to be
correlated with, dementia and mortality.[16–18] They are
related to cognitive function and their preventable and
treatable causes should be revealed.[19,20] Even though het-
erogeneous pathological relations exist, the presence of
gliosis related to focal myelinosis, axonal loss and hyali-
nosis suggests a role of chronic hypoperfusion in the
development of hyperintense foci.[21,22] Obstructive sleep
apnea is related to the development of hypertension and
hypertension was correlated with the development of
hyperintense foci.[16,23,24] Therefore, the presence of a cor-
relation between OSA and the presence of hyperintense
foci is reasonable.[25] In this study, a correlation between
CT90 value and the presence of hyperintense foci in the
brain could not be found. However, a correlation was
found between CT95 value and number of hyperintense
foci in the brain (p=0.011). 
Increased activation of platelets plays an important role
in the development of cardiovascular complications.[26]
Some authors have indicated an increase in platelet activa-
tion and aggregation.[27–30] Mean platelet volume is an indi-
cator of thrombocytic activation and plays a role in the
pathophysiology of cardiovascular diseases as hyperten-
sion, diabetes, hypercholesterolemia and acute myocardial
infarction.[26,31] In this study, a statistically significant corre-
lation was not detected between mean platelet volume,
CT90 and CT95 values. Besides, statistically significant
effect of smoking on CT95 (p=0.017) was seen; however, it
did not affect CT90 values. 
Polysomnographic, brain MR and blood values
obtained at different time points because of retrospective
design of the study and a scarce number of cases are major
limitations of our study. Besides among cases who had
undergone polysomnographic examinations, selection of
only those who had cerebral MR and biochemical values
might create a bias towards the cases who had health prob-
lems apart from OSA.
Based on the results of this study, correlations exist
between CT90 value, AHI, BMI, Epworth sleep score,
Table 4. Factors affecting CT90 and CT95 (multivariate linear regression analysis).
Regression coefficient p value R2
(95% confidence interval)
CT90 Retroplatal Müller stage 0.419 (-2.58–3.419) 0.781 49%
Retroglossal Müller stage 3.659 (-0.501–7.818) 0.084
Smoking -0.049 (-5.719–5.621) 0.986
Diabetes 1.440 (-6.331–9.211) 0.712
Apnea hipopnea index 0.384 (-0.168–0.936) 0.169
Body mass index 0.173 (0.022–0.323) 0.026
Number of hyperintense foci 0.834 (0.180–1.488) 0.013
CT95 Retroplatal Müller stage 1.546 (-5.041–8.133) 0.641 47.9%
Retroglossal Müller stage -5.783 (-14.873–3.307) 0.208
Smoking 21.198 (8.906–33.490) 0.001
Diabetes 6.337 (-10.440–23.114) 0.453
Apnea hipopnea index 0.504 (0.178–0.830) 0.003
Body mass index 1.052 (-0.334–2.439) 0.134
Number of hyperintense foci 8.615 (1.855–15.376) 0.013
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retropalatal, retroglossal stage and presence of diabetes.
On the other hand, CT95 value is correlated with AHI,
BMI, diabetes, smoking and number of hyperintense foci
detected on brain MR. In multivariate linear regression
analysis, CT90 value was correlated with only AHI and
BMI and CT95 value was correlated with AHI, smoking
and a number of hyperintense foci in the brain. Since CT95
values are affected by smoking without any statistically sig-
nificant correlation with retropalatal and retroglossal
Müller stages, we think that consideration of CT90 value
will be more appropriate in the evaluation of the severity
of chronic intermittent hypoxia in patients with obstruc-
tive sleep apnea. However, the correlation between CT90
value and AHI is closer to the value indicated in the liter-
ature, but not stronger.
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